(NASDAQ: TELA) Tela Bio's forecast annual revenue growth rate of 37.07% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 19.74%.
Tela Bio's revenue in 2025 is $68,649,000.On average, 2 Wall Street analysts forecast TELA's revenue for 2025 to be $3,706,452,486, with the lowest TELA revenue forecast at $3,690,697,109, and the highest TELA revenue forecast at $3,722,207,864.
In 2026, TELA is forecast to generate $4,592,692,454 in revenue, with the lowest revenue forecast at $4,439,077,526 and the highest revenue forecast at $4,746,307,382.